4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-021802
Options or other derivatives
- Director acquired 12,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Harwin Peter Evan Director | 2022-06-08 | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | I | ||
Loading xslF345X03/doc4.xml…